Results 281 to 290 of about 197,837 (340)
Auricular transcutaneous vagus nerve stimulation stabilizes event segmentation through modulation of working memory representations. [PDF]
Zhou X +5 more
europepmc +1 more source
Efficacy of transcutaneous auricular vagus nerve stimulation in treating patients with post-stroke motor disorders: a prospective study. [PDF]
Xue R, Ma J.
europepmc +1 more source
The efficacy and safety of vagus nerve stimulation in pediatric epilepsy in China: a multicenter cohort study. [PDF]
Liu W, Li W, Zhao C, Wu X, Zhou D.
europepmc +1 more source
Vagus nerve stimulation for chronic pain management: Mechanisms and clinical advances. [PDF]
Patel M +6 more
europepmc +1 more source
The role of transcutaneous auricular vagus nerve stimulation in chronic pain: from neurobiological mechanisms to clinical applications. [PDF]
Zhang J +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Epilepsia, 1998
Summary: Left vagus nerve stimulation (VNS) is a promising new treatment for epilepsy. In 1997, VNS was approved in the United States as an adjunctive treatment for medically refractory partial‐onset seizures in adults and adolescents. For some patients with partial‐onset seizures, the adverse effects of antiepileptic drugs (AEDs) are intolerable; for
S C, Schachter, C B, Saper
openaire +3 more sources
Summary: Left vagus nerve stimulation (VNS) is a promising new treatment for epilepsy. In 1997, VNS was approved in the United States as an adjunctive treatment for medically refractory partial‐onset seizures in adults and adolescents. For some patients with partial‐onset seizures, the adverse effects of antiepileptic drugs (AEDs) are intolerable; for
S C, Schachter, C B, Saper
openaire +3 more sources
Arthritis & Rheumatology, 2023
Preliminary evidence suggests that vagus nerve stimulation (VNS) may have some benefit in patients with rheumatoid arthritis (RA); however, prior studies have been small and/or uncontrolled; this study aimed to address that gap.
Matthew C. Baker +8 more
semanticscholar +1 more source
Preliminary evidence suggests that vagus nerve stimulation (VNS) may have some benefit in patients with rheumatoid arthritis (RA); however, prior studies have been small and/or uncontrolled; this study aimed to address that gap.
Matthew C. Baker +8 more
semanticscholar +1 more source
Brain Stimulation, 2022
BACKGROUND There are 9.9 million new cases of dementia in the world every year. Short-term conversion rate from mild cognitive impairment (MCI) to dementia is between 20% and 40%, but long-term in 5-10 years ranges from 60% to 100%.
Lei Wang +16 more
semanticscholar +1 more source
BACKGROUND There are 9.9 million new cases of dementia in the world every year. Short-term conversion rate from mild cognitive impairment (MCI) to dementia is between 20% and 40%, but long-term in 5-10 years ranges from 60% to 100%.
Lei Wang +16 more
semanticscholar +1 more source

